Furthermore, a notable disparity DSS was observed between patients exhibiting high CENPW expression and those with lower CENPW expression in the TCGA-BLCA dataset (n=385, Hazard Ratio (HR) = 1.51, P (HR) = 0.02; Figure 2G). The gene discussed is CENPW; the disease is bladder transitional cell carcinoma.